Cargando…

Functional and Clinical Impact of CircRNAs in Oral Cancer

The increasing number of recently published works regarding the role of circular RNAs (circRNAs) in oral cancer highlights the key contribution of this novel class of endogenous noncoding RNAs as regulators of critical signaling pathways and their clinical value as novel biomarkers. This review summ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cristóbal, Ion, Caramés, Cristina, Rubio, Jaime, Sanz-Alvarez, Marta, Luque, Melani, Madoz-Gúrpide, Juan, Rojo, Federico, García-Foncillas, Jesús
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226580/ https://www.ncbi.nlm.nih.gov/pubmed/32340253 http://dx.doi.org/10.3390/cancers12041041

Ejemplares similares

Deregulation of the miR-19b/PPP2R5E Signaling Axis Shows High Functional Impact in Colorectal Cancer Cells
por: Santos, Andrea, et al.
Publicado: (2023)

Low MicroRNA-19b Expression Shows a Promising Clinical Impact in Locally Advanced Rectal Cancer
por: Rubio, Jaime, et al.
Publicado: (2021)

Validation of microRNA-199b as A Promising Predictor of Outcome and Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer Patients
por: Cristóbal, Ion, et al.
Publicado: (2021)

MicroRNA-19b Plays a Key Role in 5-Fluorouracil Resistance and Predicts Tumor Progression in Locally Advanced Rectal Cancer Patients
por: Santos, Andrea, et al.
Publicado: (2022)

MicroRNA-199b Deregulation Shows Oncogenic Properties and Promising Clinical Value as Circulating Marker in Locally Advanced Rectal Cancer Patients
por: Santos, Andrea, et al.
Publicado: (2022)

The Role of MicroRNAs in Hepatoblastoma Tumors
por: Cristóbal, Ion, et al.
Publicado: (2019)

Deregulation of SET is Associated with Tumor Progression and Predicts Adverse Outcome in Patients with Early-Stage Colorectal Cancer
por: Cristóbal, Ion, et al.
Publicado: (2019)

MicroRNA-199b Deregulation Shows a Strong SET-Independent Prognostic Value in Early-Stage Colorectal Cancer
por: Cristóbal, Ion, et al.
Publicado: (2020)

MicroRNA-199b Downregulation Confers Resistance to 5-Fluorouracil Treatment and Predicts Poor Outcome and Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients
por: Cristóbal, Ion, et al.
Publicado: (2020)

Expression of Phosphorylated BRD4 Is Markedly Associated with the Activation Status of the PP2A Pathway and Shows a Strong Prognostic Value in Triple Negative Breast Cancer Patients
por: Sanz-Álvarez, Marta, et al.
Publicado: (2021)

Potential therapeutic value of miR‐425‐5p in metastatic colorectal cancer
por: Cristóbal, Ion, et al.
Publicado: (2016)

Activation of MET pathway predicts poor outcome to cetuximab in patients with recurrent or metastatic head and neck cancer
por: Madoz-Gúrpide, Juan, et al.
Publicado: (2015)

CIP2A as a Key Regulator for AKT Phosphorylation Has Partial Impact Determining Clinical Outcome in Breast Cancer
por: Luque, Melani, et al.
Publicado: (2022)

Comment on ‘MicroRNA-214 suppresses growth, migration and invasion through a novel target, high mobility group AT-hook 1, in human cervical and colorectal cancer cells’
por: Cristóbal, Ion, et al.
Publicado: (2017)

Downregulation of microRNA-199b predicts unfavorable prognosis and emerges as a novel therapeutic target which contributes to PP2A inhibition in metastatic colorectal cancer
por: Cristóbal, Ion, et al.
Publicado: (2016)

Thymidylate synthase expression as a predictive biomarker of pemetrexed sensitivity in advanced non-small cell lung cancer
por: Chamizo, Cristina, et al.
Publicado: (2015)

Tumor-Infiltrating Lymphocytes and Immune Response in HER2-Positive Breast Cancer
por: Luque, Melani, et al.
Publicado: (2022)

Comment on ‘TAp63 suppress metastasis via miR-133b in colon cancer cells'
por: Cristobal, I, et al.
Publicado: (2014)

The Hippo Pathway Transducers YAP1/TEAD Induce Acquired Resistance to Trastuzumab in HER2-Positive Breast Cancer
por: González-Alonso, Paula, et al.
Publicado: (2020)

Targeted Therapy Modulates the Secretome of Cancer-Associated Fibroblasts to Induce Resistance in HER2-Positive Breast Cancer
por: Luque, Melani, et al.
Publicado: (2021)

The Novel Oral mTORC1/2 Inhibitor TAK-228 Reverses Trastuzumab Resistance in HER2-Positive Breast Cancer Models
por: Sanz-Álvarez, Marta, et al.
Publicado: (2021)

MicroRNAs in Rectal Cancer: Functional Significance and Promising Therapeutic Value
por: Imedio, Laura, et al.
Publicado: (2020)

Activation of the Tumor Suppressor PP2A Emerges as a Potential Therapeutic Strategy for Treating Prostate Cancer
por: Cristóbal, Ion, et al.
Publicado: (2015)

Phosphorylated protein phosphatase 2A determines poor outcome in patients with metastatic colorectal cancer
por: Cristóbal, I, et al.
Publicado: (2014)

From circRNAs to fusion circRNAs in hematological malignancies
por: Babin, Loelia, et al.
Publicado: (2021)

Pyrosequencing-Based Assays for Rapid Detection of HER2 and HER3 Mutations in Clinical Samples Uncover an E332E Mutation Affecting HER3 in Retroperitoneal Leiomyosarcoma
por: González-Alonso, Paula, et al.
Publicado: (2015)

Translation of CircRNAs
por: Pamudurti, Nagarjuna Reddy, et al.
Publicado: (2017)

PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effects
por: Rincón, Raúl, et al.
Publicado: (2015)

LncRNAs and CircRNAs in cancer
por: Yin, Xin, et al.
Publicado: (2022)

The role of circRNAs in cancers
por: Zhu, Ling-Ping, et al.
Publicado: (2017)

The coding potential of circRNAs
por: Das, Aniruddha, et al.
Publicado: (2018)

CircRNAs in Tumor Radioresistance
por: Gao, Yining, et al.
Publicado: (2022)

CircPrimer 2.0: a software for annotating circRNAs and predicting translation potential of circRNAs
por: Zhong, Shanliang, et al.
Publicado: (2022)

Interactions of circRNAs with methylation: An important aspect of circRNA biogenesis and function
por: Zhang, Chunlei, et al.
Publicado: (2022)

CircPrimer: a software for annotating circRNAs and determining the specificity of circRNA primers
por: Zhong, Shanliang, et al.
Publicado: (2018)

Circular RNAs (circRNAs) in Health and Disease
por: Haque, Shahnaz, et al.
Publicado: (2017)

Immunotherapy for Peritoneal Metastases from Gastric Cancer: Rationale, Current Practice and Ongoing Trials
por: Ruiz Hispán, Eva, et al.
Publicado: (2021)

Comprehensive CircRNA Profiling and Selection of Key CircRNAs Reveal the Potential Regulatory Roles of CircRNAs throughout Ovarian Development and Maturation in Cynoglossus semilaevis
por: Li, Jing, et al.
Publicado: (2021)

CircRNAs in hematopoiesis and hematological malignancies
por: Bonizzato, A, et al.
Publicado: (2016)

Roles of CircRNAs in Autoimmune Diseases
por: Xia, Xin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d3vhq9d11uqugf11bsn1lgbajk